Trial
NCT03727633
Hepatocellular Carcinoma on Cirrhosis With Child A/B7 and Hepatic Intra Arterial Injection of Idarubicin/Lipiodol Emulsion
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University Hospital, Montpellier
Collaborators
Guerbet
Condition
Carcinoma, Hepatocellular
Intervention
Idarubicin and Lipiodol
Why stopped
Enrollement rythm low, funding body decision.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-31